Top Cardiac Prosthetic Devices Companies

Skyquest Technology's expert advisors have carried out comprehensive research and identified these companies as industry leaders in the Cardiac Prosthetic Devices Market. This Analysis is based on comprehensive primary and secondary research on the corporate strategies, financial and operational performance, product portfolio, market share and brand analysis of all the leading Cardiac Prosthetic Devices industry players.

Cardiac Prosthetic Devices Market Competitive Landscape

The global cardiac prosthetic devices market competitive scenario is dominated by Edwards Lifesciences, Medtronic, Abbott Laboratories, and Boston Scientific. These firms operate with innovation, mergers and acquisitions to keep the leadership intact. Edwards Lifesciences leads with research efforts in heart valve technologies, Medtronic continues to expand minimally invasive surgery solutions, and Abbott supplements its product portfolio with strategic acquisitions for a wide offering of advanced cardiac solutions.

The startup ecosystem in the global cardiac prosthetic devices market outlook is expanding fast, with new-age companies launching cutting-edge solutions for heart valve replacement and vascular repair. These startups are developing minimally invasive treatments, bioresorbable technologies, and personalized medicine to enhance patient outcomes. They are leading tremendous R&D breakthroughs, making cardiovascular therapies more affordable, effective, and cost-saving for a larger patient base.

  • Founded in 2015, Xeltis is a medical device startup pioneering bioresorbable cardiac implants. Their flagship product, the Bioabsorbable Heart Valve, is designed to replace damaged heart valves and gradually absorb over time, allowing natural tissue growth. This pioneering technology encourages the body's own natural healing process, without the need for subsequent surgeries and offering long-term, sustainable solutions to valve replacement, particularly for younger patients.
  • Established in 2016, CardioMech focuses on minimally invasive solutions for mitral valve repair. Their CardioMech Mitral Valve Repair System uses a catheter-based procedure to restore valve function without open-heart surgery. The company's breakthrough R&D is aimed at creating a device that improves outcomes for patients with heart valve disease, particularly those at high surgical risk, by offering a safer, less invasive treatment with faster recovery times and reduced complications.

Top Player’s Company Profiles

  • Edwards Lifesciences (USA)
  • Medtronic (Ireland)
  • Abbott Laboratories (USA)
  • Boston Scientific (USA)
  • CryoLife (USA)
  • Terumo Corporation (Japan)
  • Johnson & Johnson (USA)
  • Sorin Group (Italy)
  • LivaNova (UK)
  • Cardinal Health (USA)
  • Biotronik (Germany)
  • Tendyne (USA)
  • Aortic Medical (USA)
  • Mitsubishi Tanabe Pharma Corporation (Japan)
  • Vascular Solutions (USA)

REQUEST FOR SAMPLE

Want to customize this report? REQUEST FREE CUSTOMIZATION

FAQs

Global Cardiac Prosthetic Devices Market size was valued at USD 7.47 Billion in 2024 and is poised to grow from USD 8.05 Billion in 2025 to USD 14.69 Billion by 2033, growing at a CAGR of 7.8% during the forecast period (2026–2033).

The global cardiac prosthetic devices market competitive scenario is dominated by Edwards Lifesciences, Medtronic, Abbott Laboratories, and Boston Scientific. These firms operate with innovation, mergers and acquisitions to keep the leadership intact. Edwards Lifesciences leads with research efforts in heart valve technologies, Medtronic continues to expand minimally invasive surgery solutions, and Abbott supplements its product portfolio with strategic acquisitions for a wide offering of advanced cardiac solutions. 'Abbott Laboratories (USA) ', 'Medtronic plc (Ireland) ', 'Boston Scientific Corporation (USA) ', 'Edwards Lifesciences Corporation (USA) ', 'LivaNova PLC (UK) ', 'Biotronik (Germany) ', 'MicroPort Scientific Corporation (China) ', 'Meril Life Sciences Pvt. Ltd. (India) ', 'Lepu Medical Technology Co., Ltd. (China) ', 'CryoLife, Inc. (USA) ', 'AtriCure, Inc. (USA) ', 'Braile Biomedica (Brazil) ', 'Labcor Laboratórios Ltda. (Brazil) ', 'Lifetech Scientific Corporation (China) ', 'Shree Pacetronix Ltd. (India) ', 'TTK Healthcare Ltd. (India) ', 'Colibri Heart Valve LLC (USA) ', 'Berlin Heart GmbH (Germany) ', 'SynCardia Systems LLC (USA) ', 'Venus Medtech (Hangzhou) Inc. (China)'

The rising incidences of cardiac diseases globally represent one of the biggest drivers in the global cardiac prosthetic devices market growth. As cardiac issues such as heart valve disease and coronary artery diseases rise, more prosthetic devices like heart valves and vascular grafts are required, which translates into greater opportunities for innovation and growth in the market.

Advancements in Minimally Invasive Procedures: The global cardiac prosthetic devices market trends are directing toward minimally invasive procedures, which reduce recovery times and risks. These kinds of devices, for example, transcatheter heart valves and catheter-based repair systems, are getting popular due to smaller incisions and faster recovery time.

As per the global cardiac prosthetic devices market analysis, North America is in the leading position in the industry because of its well-developed healthcare infrastructure, high incidence of cardiovascular diseases, and early acceptance of new medical technologies. Strong regulatory systems, growing healthcare expenditure, and aging population are also the advantages that this region enjoys. Moreover, the presence of major market players and active clinical trials for future-generation prosthetic devices are adding strength to North America's on-going dominance and technological superiority in this space.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Cardiac Prosthetic Devices Market
Cardiac Prosthetic Devices Market

Report ID: SQMIG35A3042

sales@skyquestt.com
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE